ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Phase 2 study of pembrolizumab in patients with bacillus Calmette-Guérin–unresponsive, high-risk, non–muscle-invasive bladder cancer: KEYNOTE-057
European Urology Supplements
◽
10.1016/s1569-9056(18)31634-8
◽
2018
◽
Vol 17
(2)
◽
pp. e1145
Author(s):
J. Bellmunt
◽
M. De Santis
◽
J. Boormans
◽
A. Kamat
◽
T. Choueiri
◽
...
Keyword(s):
Bladder Cancer
◽
High Risk
◽
Invasive Bladder Cancer
◽
Phase 2
◽
Bacillus Calmette Guerin
◽
Muscle Invasive Bladder Cancer
◽
Phase 2 Study
◽
Muscle Invasive
Download Full-text
Related Documents
Cited By
References
Updated follow-up from KEYNOTE-057: Phase 2 study of pembrolizumab (pembro) for patients (pts) with high-risk (HR) non–muscle invasive bladder cancer (NMIBC) unresponsive to bacillus Calmette-Guérin (BCG)
European Urology Open Science
◽
10.1016/s2666-1683(20)33372-3
◽
2020
◽
Vol 19
◽
pp. e1173-e1174
Author(s):
J.L. Boormans
◽
R. De Wit
◽
G.S. Kulkarni
◽
E.M. Uchio
◽
M. Roumiguié
◽
...
Keyword(s):
Bladder Cancer
◽
High Risk
◽
Invasive Bladder Cancer
◽
Phase 2
◽
Bacillus Calmette Guerin
◽
Muscle Invasive Bladder Cancer
◽
Phase 2 Study
◽
Muscle Invasive
Download Full-text
KEYNOTE-057: Phase 2 study of pembrolizumab for patients (pts) with Bacillus Calmette Guerin (BCG)-unresponsive, high-risk non-muscle-invasive bladder cancer (NMIBC).
Journal of Clinical Oncology
◽
10.1200/jco.2016.34.15_suppl.tps4576
◽
2016
◽
Vol 34
(15_suppl)
◽
pp. TPS4576-TPS4576
◽
Cited By ~ 6
Author(s):
Ashish M. Kamat
◽
Joaquim Bellmunt
◽
Toni K. Choueiri
◽
Kijoeng Nam
◽
Maria De Santis
◽
...
Keyword(s):
Bladder Cancer
◽
High Risk
◽
Invasive Bladder Cancer
◽
Phase 2
◽
Bacillus Calmette Guerin
◽
Muscle Invasive Bladder Cancer
◽
Phase 2 Study
◽
Muscle Invasive
Download Full-text
MP43-01 PHASE 2 KEYNOTE-057 STUDY: PEMBROLIZUMAB FOR PATIENTS WITH HIGH-RISK NON–MUSCLE INVASIVE BLADDER CANCER UNRESPONSIVE TO BACILLUS CALMETTE-GUERIN
The Journal of Urology
◽
10.1097/01.ju.0000556224.50163.ad
◽
2019
◽
Vol 201
(Supplement 4)
◽
Author(s):
Girish S. Kulkarini*
◽
Ronald de Wit
◽
Arjun V. Balar
◽
Ashish Kamat
◽
Edward Uchio
◽
...
Keyword(s):
Bladder Cancer
◽
High Risk
◽
Invasive Bladder Cancer
◽
Phase 2
◽
Bacillus Calmette Guerin
◽
Muscle Invasive Bladder Cancer
◽
Muscle Invasive
Download Full-text
Pembrolizumab in patients with Bacillus Calmette Guérin (BCG)-unresponsive, high-risk non–muscle-invasive bladder cancer (NMIBC): Phase 2 KEYNOTE-057 study
Annals of Oncology
◽
10.1093/annonc/mdw373.76
◽
2016
◽
Vol 27
◽
pp. vi294
Author(s):
R. de Wit
◽
A.M. Kamat
◽
J. Bellmunt
◽
T.K. Choueiri
◽
K. Nam
◽
...
Keyword(s):
Bladder Cancer
◽
High Risk
◽
Invasive Bladder Cancer
◽
Phase 2
◽
Bacillus Calmette Guerin
◽
Muscle Invasive Bladder Cancer
◽
Muscle Invasive
Download Full-text
Pembrolizumab for patients with high-risk non–muscle invasive bladder cancer unresponsive to bacillus Calmette-Guérin: The phase 2 KEYNOTE-057 study
European Urology Supplements
◽
10.1016/s1569-9056(19)30557-3
◽
2019
◽
Vol 18
(1)
◽
pp. e758-e759
◽
Cited By ~ 1
Author(s):
J.L. Boormans
◽
A.V. Balar
◽
R. De Wit
◽
A. Kamat
◽
E. Uchio
◽
...
Keyword(s):
Bladder Cancer
◽
High Risk
◽
Invasive Bladder Cancer
◽
Phase 2
◽
Bacillus Calmette Guerin
◽
Muscle Invasive Bladder Cancer
◽
Muscle Invasive
Download Full-text
A phase 2, randomized study of nivolumab or nivolumab plus BMS-986205 with or without intravesical bacillus Calmette-Guerin in patients with bacillus Calmette-Guerin–unresponsive, high-risk, non-muscle invasive bladder cancer: CheckMate 9UT
European Urology Supplements
◽
10.1016/s1569-9056(19)31328-4
◽
2019
◽
Vol 18
(1)
◽
pp. e1833-e1834
◽
Cited By ~ 1
Author(s):
J.A. Witjes
◽
J. Gschwend
◽
J. Palou
◽
M. Meng
◽
S. Chang
◽
...
Keyword(s):
Bladder Cancer
◽
High Risk
◽
Randomized Study
◽
Invasive Bladder Cancer
◽
Phase 2
◽
Bacillus Calmette Guerin
◽
Muscle Invasive Bladder Cancer
◽
Muscle Invasive
Download Full-text
Pembrolizumab monotherapy for the treatment of high-risk non-muscle-invasive bladder cancer unresponsive to BCG (KEYNOTE-057): an open-label, single-arm, multicentre, phase 2 study
The Lancet Oncology
◽
10.1016/s1470-2045(21)00147-9
◽
2021
◽
Author(s):
Arjun V Balar
◽
Ashish M Kamat
◽
Girish S Kulkarni
◽
Edward M Uchio
◽
Joost L Boormans
◽
...
Keyword(s):
Bladder Cancer
◽
High Risk
◽
Invasive Bladder Cancer
◽
Phase 2
◽
Open Label
◽
Muscle Invasive Bladder Cancer
◽
Multicentre Phase
◽
Phase 2 Study
◽
Muscle Invasive
Download Full-text
Re: Pembrolizumab Monotherapy for the Treatment of High-risk Non-muscle-invasive Bladder Cancer Unresponsive to BCG (KEYNOTE-057): An Open-label, Single-arm, Multicentre, Phase 2 Study
European Urology
◽
10.1016/j.eururo.2021.07.020
◽
2021
◽
Author(s):
Arshvin Kesavan
◽
Kesavan Esuvaranathan
Keyword(s):
Bladder Cancer
◽
High Risk
◽
Invasive Bladder Cancer
◽
Phase 2
◽
Open Label
◽
Muscle Invasive Bladder Cancer
◽
Multicentre Phase
◽
Phase 2 Study
◽
Muscle Invasive
Download Full-text
Partial Versus Complete Bacillus Calmette-Guérin Intravesical Therapy and Bladder Cancer Outcomes in High-risk Non–muscle-invasive Bladder Cancer: Is NIMBUS the Full Story?
European Urology Open Science
◽
10.1016/j.euros.2021.01.009
◽
2021
◽
Vol 26
◽
pp. 35-43
Author(s):
Michael E. Rezaee
◽
A. Aziz Ould Ismail
◽
Chiamaka L. Okorie
◽
John D. Seigne
◽
Kristine E. Lynch
◽
...
Keyword(s):
Bladder Cancer
◽
High Risk
◽
Invasive Bladder Cancer
◽
Intravesical Therapy
◽
Bacillus Calmette Guerin
◽
Cancer Outcomes
◽
Muscle Invasive Bladder Cancer
◽
Muscle Invasive
Download Full-text
Safety evaluation of sequential Mitomycin and Bacillus Calmette-Guérin treatment versus Bacillus Calmette-Guérin monotherapy in patients with high risk non-muscle invasive bladder cancer: MITOBCG study (EUDRACT Number 2017-004540-37) preliminary results
European Urology
◽
10.1016/s0302-2838(21)00829-0
◽
2021
◽
Vol 79
◽
pp. S618-S619
Author(s):
C. De Nunzio
◽
A. Nacchia
◽
R. Lombardo
◽
O.A. Voglino
◽
V. Baldassarri
◽
...
Keyword(s):
Bladder Cancer
◽
High Risk
◽
Safety Evaluation
◽
Invasive Bladder Cancer
◽
Bacillus Calmette Guerin
◽
Muscle Invasive Bladder Cancer
◽
Preliminary Results
◽
Muscle Invasive
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close